Epidemiological studies suggest that cigarette smoke carcinogens are cofactors which synergize with human papillomavirus (HPV) to increase the risk of cervical cancer progression. Benzo[a]pyrene (BaP), a major carcinogen in cigarette smoke, is detected in the cervical mucus and may interact with HPV. Exposure of cervical cells to high concentrations of BaP resulted in a 10-fold increase in HPV type 31 (HPV31) viral titers, whereas treatment with low concentrations of BaP resulted in an increased number of HPV genome copies but not an increase in virion morphogenesis. BaP exposure also increased HPV16 and HPV18 viral titers. Overall, BaP modulation of the HPV life cycle could potentially enhance viral persistence, host tissue carcinogenesis, and permissiveness for cancer progression.Worldwide, cervical cancer is the third most prevalent type of female cancer and ranks second as a cause of cancer-related deaths in women (49). Human papillomavirus (HPV) is causatively linked to over 90% of all cervical cancer cases examined (5,20,42,51,55). Most cases of HPV-induced dysplasia spontaneously regress over time (18), and only a small percentage of women infected with oncogenic "high-risk" HPV types, such as HPV type 16 (HPV16), HPV18, and HPV31, progress to high-grade squamous intraepithelial lesions and cervical cancer (4, 10). Epidemiological studies suggest that environmental and host-related cofactors act in conjunction with HPV to promote malignant progression of cervical lesions (7). It has been proposed that cigarette smoking among HPV-positive women is one of the cofactors which likely influences the risk for cervical cancer progression (15,21,27,38,41,50,52,54). Tobacco-specific polycyclic aromatic hydrocarbons such as benzo[a]pyrene (BaP) (31) and nitrosamines such as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) (43), which are potent inducers of carcinogenesis (12,16,28), have been detected in the cervical mucus of women who smoke and exhibit cervical dysplasias (19,29,47). Quantitative levels of noncarcinogenic nicotine and its metabolite cotinine in cervical mucus were correlated with smoking intensity (29,47,48) and were shown to be concentrated more strongly in cervical mucus than in blood (17). Colocalization of HPV and cigarette smoke carcinogens in the cervix may present an opportunity for virus/ carcinogen interaction (15).Molecular mechanisms targeted by cigarette smoke carcinogens which potentially deregulate the HPV life cycle and which may promote cervical cancer progression have not been addressed. In this study, we demonstrate for the first time that BaP, a major carcinogenic constituent of cigarette smoke, stimulates high levels of virion synthesis in cell lines productively infected with HPV.We have previously demonstrated that the complete HPV life cycle is strictly dependent on host tissue differentiation (2,14,32,33,35,36,40). Utilizing the in vitro organotypic raft culture system and the CIN-612 9E cervical intraepithelial neoplasia type I biopsy-derived cell line, our laboratory ...